Feb 9, 2026 5:20 pm EST VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Feb 4, 2026 8:45 am EST Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation
Jan 30, 2026 8:50 am EST VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays
Jan 8, 2026 8:45 am EST VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats
